ViewsWeek Views from around the world
The Oxford vaccine, based on a viral vector, is also cheaper (around US$4) than Pfizer and Moderna’s mRNA vaccines – around US$20 and $33, respectively. AstraZeneca has made a “no profit pledge”.
Read More »Why the Oxford AstraZeneca Vaccine is Now a Global Game-changer
